Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection
NCT02765802Phase 2Completed
- Start
- Oct 2016
- Primary completion
- Jul 2018
- Modality
- Cytokines & Interferons
- Countries
- 3
01
Overview
Phase 2, randomised, open-label trial of peginterferon lambda-1a in hepatitis D (HDV) (2 arms). Primary endpoint: Change From Baseline in HDV Viral Load at 48 weeks. Started Oct 2016; status: completed.
02
Drugs
peginterferon lambda-1a
03
Conditions
hepatitis D (HDV)
Beyond the preview
Go deeper on NCT02765802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02765802.